AI-generated picture

From time to time, we share insights into the advantages our customers and partners gain from using additives from the bFI product family. These findings are based on applications and trials, often sparking ideas for additional use cases where, for instance, the bFI A 3745 provides the necessary solution.

Wide Range of Application Opportunities

Originally developed on an acrylate basis, the flow enhancers of the bFI product family were initially intended for use primarily in acrylic glass, polycarbonate, and polystyrene. However, as described elsewhere, the compatibility of these polymeric additives extends well beyond this scope. They can be applied across all common plastic variants, including both thermoplastics and thermosets, effectively addressing a wide range of viscosity challenges.

In addition to our research findings, validated in collaboration with partners, positive feedback from customers and documented case studies further confirm the efficacy, reproducibility, and stability of our polymeric additives.

What advantages does the bFI product family offer you?

We observe a range of benefits in both the processing phase and the additive-enhanced material, which consistently appear across applications.

Here is a brief selection:

  • Reduction in viscosity (significant increase in MFR or MVR)
  • Increased productivity through shorter cycle times
  • Lower processing pressures and temperatures
  • Potential energy savings, thus reducing the CO2 footprint
  • Greater flexibility in choosing injection molding machines, extruders, etc.
  • Enhanced flexibility in raw material selection, whether polymers or additional components (e.g., regranulates, temperature-sensitive additives)

Our customers, well-acquainted with their own processes, can often quickly identify secondary advantages from these points. This success is often achieved in the form of thin-walled components made from specialized materials that would not have been feasible without the bFI additive.

Current Findings

Understandably, we cannot discuss many of our shared successes with customers. However, here’s what we’ve learned in recent months: Biomaterials also pose no issue for polymeric additives like the bFI A 3745. Their processing temperature range can be significantly expanded. We will provide more detailed information on this elsewhere.

It is also possible to process regranulates, even from post-consumer sources, consistently and at an injection molding material level. Alongside rPMMA and rPET, rPP can also be optimized for flowability, standardizing the quality of purchased materials.

Both points offer real added value for our customers in times of changing raw material cycles and increasing sustainability demands. Let’s tackle it together!